INTRODUCTION: Cytomegalovirus is a common virus responsible for a wide range of clinical manifestations. Hemolysis is a rare but potentially life-threatening complication of cytomegalovirus infection, described mostly in immunocompromised patients, the pathogenesis of which is still unclear.We performed a review of the literature regarding cases of hemolytic anemia during acute cytomegalovirus infection in apparently immunocompetent individuals. We searched for relevant articles in PubMed for the period of 1980 through 2008. CASE PRESENTATION: We describe a case of Coombs-negative hemolytic anemia in a 44-year-old Caucasian immunocompetent man with acute cytomegalovirus infection. CONCLUSION: Clinicians should consider cytomegalovirus infection in the differential diagnosis of hemolytic anemia in immunocompetent adults. Possible therapeutic options include antiviral therapy and steroids, although the best treatment strategy is still controversial.
INTRODUCTION:Cytomegalovirus is a common virus responsible for a wide range of clinical manifestations. Hemolysis is a rare but potentially life-threatening complication of cytomegalovirus infection, described mostly in immunocompromised patients, the pathogenesis of which is still unclear.We performed a review of the literature regarding cases of hemolytic anemia during acute cytomegalovirus infection in apparently immunocompetent individuals. We searched for relevant articles in PubMed for the period of 1980 through 2008. CASE PRESENTATION: We describe a case of Coombs-negative hemolytic anemia in a 44-year-old Caucasian immunocompetent man with acute cytomegalovirus infection. CONCLUSION: Clinicians should consider cytomegalovirus infection in the differential diagnosis of hemolytic anemia in immunocompetent adults. Possible therapeutic options include antiviral therapy and steroids, although the best treatment strategy is still controversial.
Authors: J C Murray; J C Bernini; H L Bijou; S N Rossmann; D H Mahoney; A B Morad Journal: J Pediatr Hematol Oncol Date: 2001 Jun-Jul Impact factor: 1.289
Authors: F Bonnet; P Morlat; D Neau; J F Viallard; J M Ragnaud; M Dupon; P Legendre; Y Imbert; F Lifermann; M Le Bras; J Beylot; M Longy-Boursier Journal: Rev Med Interne Date: 2000-07 Impact factor: 0.728
Authors: Thomas Stockdale; Tom Hosack; Cameron Griffiths; Amit Kj Mandal; Constantinos G Missouris Journal: Clin Med (Lond) Date: 2020-06-17 Impact factor: 2.659